Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Dey, L.P. et al v. Sepracor, Inc.
Case Number:
1:07-cv-02353
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 02, 2012
Sunovion Knocks Out 5 Patents In Mylan's Brovana Suit
Mylan Inc. on Friday vowed to appeal after a New York federal judge ruled that five patents asserted against Sunovion Pharmaceuticals Inc. in a suit over the chronic pulmonary obstructive disease drug Brovana were invalid, and limited potential damages on the two other patents-in-suit.
-
March 18, 2010
Claims Pared In Dey, Sepracor IP Fight Over Brovana
Sepracor Inc. and Dey LP have agreed to dismiss a range of individual patent claims in their battle over Sepracor's rollout of chronic obstructive pulmonary disease drug Brovana.